Paragon BioTeck, a privately held pharmaceutical and clinical gadget enterprise specializing within the development and commercialization of ophthalmic prescription drugs, gadgets and treatment plans, currently completed the reformulation for the FRESHKOTE ® family of lubricant eye lessens, purchased this week with the aid of Eyevance prescribed drugs.

“we’re completely satisfied to be in a position to have a job in the advancements made to the FRESHKOTE ® products that make the product line an alluring acquisition for Eyevance,” pointed out Patrick Witham, president and CEO of Paragon BioTeck. “FRESHKOTE ® PF, which we formulated as a preservative-free product accessible in a multi-dose bottle and in single-unit vials, should be a welcome boost for physicians who were looking for a preservative-free product to advocate to their patients.”

Physicians have already taken be aware of the advancements made in FRESHKOTE ® . “Of the entire bottled synthetic tears that i exploit in my Dry Eye center of Excellence, FRESHKOTE ® is my favourite,” observed Marguerite McDonald, MD, FACS. “The individuals who purchase FRESHKOTE ® purchase synthetic tears less generally since the effect is so long.”

“It’s been a pleasure working with the Paragon team to make this acquisition a fact,” referred to Jerry St. Peter, CEO and director of Eyevance. “The brilliant efforts made through their building crew to convey FRESHKOTE ® PF to market offers Eyevance a different product. We seem to be ahead to marketing FRESHKOTE ® PF to eye care practitioners nationwide.”

committed to enhancing the satisfactory of life of patients, Paragon BioTeck develops and commercializes eye fitness items. The company’s product portfolio contains branded over-the-counter and prescription solutions to diagnose, manage and deal with ocular situations.

“Our scientists were in particular joyful to have the ability to improve a preservative-free formulation that is protected and smartly-tolerated with the aid of sufferers donning contact lenses,” Witham delivered. “This challenge extra demonstrates our mission to developing new and innovative items and technologies that enhance ocular medicine.”

About Paragon BioTeck Paragon BioTeck, ., is a privately held pharmaceutical and scientific machine enterprise specializing in the construction and commercialization of ophthalmic pharmaceuticals, devices and cures. Paragon BioTeck’s portfolio of products is designed to protect and hold eyesight and convey comfort to the eyes. gain knowledge of greater about Paragon BioTeck at paragonbioteckm.

View supply edition on businesswirem:

Paragon BioTeck, .”> <Property FormalName.”PrimaryTwitterHandle” price=”ParagonBioTeck

For Paragon BioTeck, . Jane Byram, 512-626-2758 SCORR advertising janescorrmarketingm

enterprise Wire 2018